Reanalysis of Popular Antidepressant Trial Uncovers Reporting Flaws
- A reanalysis of a study found that fluoxetine alone showed no measurable benefit over placebo in treating adolescent depression after 12 weeks
- Researchers uncovered 11 additional suicide-related events that were hidden or misclassified, bringing the total to 21 serious incidents
- Statistical tactics and selective reporting made fluoxetine appear safer and more effective than it really was in clinical trials
- A different reanalysis mentioned that adverse events and many side effects were minimized or excluded from the original reports
- Improving gut health, getting regular exercise, undergoing therapy, and optimizing vitamin D are viable approaches for treating depression
You May Also Like

The Overwhelmed Brain
Paul Colaianni: Relationship and Emotional Abuse Expert

The Resilient Man | Daily Stoic Affirmations
Motivation

Mindset Reset | Daily Motivation
Motivation

Mental Gym Daily | Train Your Toughness
Motivation

Productivity Mindset Mornings | Daily Affirmations
Motivation

Masculine Mindset | Affirmations for Men
Motivation

Self-Love Affirmations for Women
Motivation

You Are Heroic with Brian Johnson
Brian Johnson

Be Calm and Relaxed with Rain and Thunder for Sleeping
ColoredJuice Podcast Studio

The Human Upgrade: Biohacking for Longevity & Performance
Dave Asprey
Community discussion